Bioventus Inc (NASDAQ:BVS) shares, rose in value, with the stock price up by 0.51% to the previous day’s close as strong demand from buyers drove the stock to $7.82.
Actively observing the price movement in the last trading, the stock closed the session at $7.78, falling within a range of $7.585 and $7.8816. The value of beta (5-year monthly) was 0.915. Referring to stock’s 52-week performance, its high was $14.38, and the low was $3.90. On the whole, BVS has fluctuated by -21.25% over the past month.
With the market capitalization of Bioventus Inc currently standing at about $640.80 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-10.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 564.86M, with a low estimate of 121M and a high estimate of 124.02M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 122.71M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that BVS’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of BVS currently trading nearly -8.93% and -17.43% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 37.22, while the 7-day volatility ratio is showing 6.29% which for the 30-day chart, stands at 6.63%. Furthermore, Bioventus Inc (BVS)’s beta value is 0.99, and its average true range (ATR) is 0.59.
A comparison of Bioventus Inc (BVS) with its peers suggests the former has fared considerably weaker in the market. BVS showed an intraday change of 0.51% in last session, and over the past year, it grew by 68.53%%.
Data on historical trading for Bioventus Inc (NASDAQ:BVS) indicates that the trading volumes over the past 10 days have averaged 0.39 and over the past 3 months, they’ve averaged 324.06K. According to company’s latest data on outstanding shares, there are 65.76 million shares outstanding.
Nearly 31.73% of Bioventus Inc’s shares belong to company insiders and institutional investors own 49.21% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.74 million shares as on 2025-03-31, resulting in a short ratio of 1.83. According to the data, the short interest in Bioventus Inc (BVS) stood at 162.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 0.79 million. The stock has fallen by -25.52% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the BVS stock heading into the next quarter.
